On October 27, 2025, Eli Lilly's board declared a fourth-quarter dividend of $1.50 per share, payable December 10, 2025 to shareholders of record as of November 14, 2025[2]. This announcement underscores the company's stable financial position and ongoing commitment to shareholder returns. Recent analysis highlights Eli Lilly's strong growth momentum, with positive earnings trends and analyst upgrades supporting a favorable technical setup for the stock[1]. The stock closed at $826.41 (+0.12%) on October 27, 2025, reflecting steady performance in line with its growth profile. No major company-specific news or events have been reported that would explain significant price movement beyond the routine dividend announcement and continued positive sentiment.